Non-medical switch from originator to biosimilar infliximab in patients with inflammatory arthritis: impact on s-infliximab and antidrug-antibodies. Results from the Danish Rheumatologic Biobank and the DANBIO registry

Bente  Glintborg; Tina Kringelbach; Estrid Høgdall; Inge Juul Sørensen; Dorte Vendelbo Jensen; Anne Gitte Loft; Oliver Hendricks; Inger Marie Jensen Hansen; Nils Bolstad; David J. Warren; Johanna Gehin; Guro Goll; Kathrine Grøn; Grith Eng; Christian Enevold; Claus Henrik Nielsen; Julia S. Johansen; Merete L. Hetland

Non-medical switch from originator to biosimilar infliximab in patients with inflammatory arthritis: impact on s-infliximab and antidrug-antibodies. Results from the Danish Rheumatologic Biobank and the DANBIO registry

Bente Glintborg, Tina Kringelbach, Estrid Høgdall, Inge Juul Sørensen, Dorte Vendelbo Jensen, Anne Gitte Loft, Oliver Hendricks, Inger Marie Jensen Hansen, Nils Bolstad, David J. Warren, Johanna Gehin, Guro Goll, Kathrine Grøn, Grith Eng, Christian Enevold, Claus Henrik Nielsen, Julia S. Johansen, Merete L. Hetland

Publikation: Bidrag til tidsskrift › Konferenceabstrakt i tidsskrift › Forskning › peer review

Originalsprog	Engelsk
Artikelnummer	OP10
Tidsskrift	Scandinavian Journal of Rheumatology
Vol/bind	45
Udgave nummer	Supplement 128
Sider (fra-til)	6
Antal sider	1
ISSN	0300-9742
Status	Udgivet - 2016
Begivenhed	36th Scandinavian Congress of Rheumatology - Harpa , Reykjavík, Island Varighed: 1. sep. 2016 → 3. sep. 2016

Konference

Konference	36th Scandinavian Congress of Rheumatology
Lokation	Harpa
Land/Område	Island
By	Reykjavík
Periode	01/09/2016 → 03/09/2016

Dokumenter og links

https://doi.org/10.1080/03009742.2016.1207299

Citationsformater

Glintborg, B., Kringelbach, T., Høgdall, E., Sørensen, I. J., Jensen, D. V., Loft, A. G., Hendricks, O., Jensen Hansen, I. M., Bolstad, N., Warren, D. J., Gehin, J., Goll, G., Grøn, K., Eng, G., Enevold, C., Nielsen, C. H., Johansen, J. S., & Hetland, M. L. (2016). Non-medical switch from originator to biosimilar infliximab in patients with inflammatory arthritis: impact on s-infliximab and antidrug-antibodies. Results from the Danish Rheumatologic Biobank and the DANBIO registry. Scandinavian Journal of Rheumatology, 45(Supplement 128), 6. [OP10]. https://doi.org/10.1080/03009742.2016.1207299

@article{db8864a550274760821e3e20a0d80197,

title = "Non-medical switch from originator to biosimilar infliximab in patients with inflammatory arthritis: impact on s-infliximab and antidrug-antibodies. Results from the Danish Rheumatologic Biobank and the DANBIO registry",

author = "Bente Glintborg and Tina Kringelbach and Estrid H{\o}gdall and S{\o}rensen, {Inge Juul} and Jensen, {Dorte Vendelbo} and Loft, {Anne Gitte} and Oliver Hendricks and {Jensen Hansen}, {Inger Marie} and Nils Bolstad and Warren, {David J.} and Johanna Gehin and Guro Goll and Kathrine Gr{\o}n and Grith Eng and Christian Enevold and Nielsen, {Claus Henrik} and Johansen, {Julia S.} and Hetland, {Merete L.}",

year = "2016",

language = "English",

volume = "45",

pages = "6",

journal = "Scandinavian Journal of Rheumatology",

issn = "0300-9742",

publisher = "Taylor & Francis",

number = "Supplement 128",

note = "36th Scandinavian Congress of Rheumatology ; Conference date: 01-09-2016 Through 03-09-2016",

}

Glintborg, B, Kringelbach, T, Høgdall, E, Sørensen, IJ, Jensen, DV, Loft, AG, Hendricks, O, Jensen Hansen, IM, Bolstad, N, Warren, DJ, Gehin, J, Goll, G, Grøn, K, Eng, G, Enevold, C, Nielsen, CH, Johansen, JS & Hetland, ML 2016, 'Non-medical switch from originator to biosimilar infliximab in patients with inflammatory arthritis: impact on s-infliximab and antidrug-antibodies. Results from the Danish Rheumatologic Biobank and the DANBIO registry', Scandinavian Journal of Rheumatology, bind 45, nr. Supplement 128, OP10, s. 6. <https://doi.org/10.1080/03009742.2016.1207299>

Non-medical switch from originator to biosimilar infliximab in patients with inflammatory arthritis : impact on s-infliximab and antidrug-antibodies. Results from the Danish Rheumatologic Biobank and the DANBIO registry. / Glintborg, Bente ; Kringelbach, Tina; Høgdall, Estrid et al.

I: Scandinavian Journal of Rheumatology, Bind 45, Nr. Supplement 128, OP10, 2016, s. 6.

Publikation: Bidrag til tidsskrift › Konferenceabstrakt i tidsskrift › Forskning › peer review

TY - ABST

T1 - Non-medical switch from originator to biosimilar infliximab in patients with inflammatory arthritis

T2 - 36th Scandinavian Congress of Rheumatology

AU - Glintborg, Bente

AU - Kringelbach, Tina

AU - Høgdall, Estrid

AU - Sørensen, Inge Juul

AU - Jensen, Dorte Vendelbo

AU - Loft, Anne Gitte

AU - Hendricks, Oliver

AU - Jensen Hansen, Inger Marie

AU - Bolstad, Nils

AU - Warren, David J.

AU - Gehin, Johanna

AU - Goll, Guro

AU - Grøn, Kathrine

AU - Eng, Grith

AU - Enevold, Christian

AU - Nielsen, Claus Henrik

AU - Johansen, Julia S.

AU - Hetland, Merete L.

PY - 2016

Y1 - 2016

M3 - Conference abstract in journal

VL - 45

SP - 6

JO - Scandinavian Journal of Rheumatology

JF - Scandinavian Journal of Rheumatology

SN - 0300-9742

IS - Supplement 128

M1 - OP10

Y2 - 1 September 2016 through 3 September 2016

ER -

Glintborg B, Kringelbach T, Høgdall E, Sørensen IJ, Jensen DV, Loft AG et al. Non-medical switch from originator to biosimilar infliximab in patients with inflammatory arthritis: impact on s-infliximab and antidrug-antibodies. Results from the Danish Rheumatologic Biobank and the DANBIO registry. Scandinavian Journal of Rheumatology. 2016;45(Supplement 128):6. OP10.